NYSE · Drug Manufacturers - General

PFE (PFE) Stock

$28.55 +0.32% NYSE: PFE Healthcare

Valuation

MetricValue
Price$28.55
Market Cap$162.72B
P/E Ratio37.39
P/B Ratio1.89
P/S Ratio2.53
EPS (TTM)$1.36
52-Week High$29.03
52-Week Low$23.58
Dividend Yield6.08%

Financials & Margins

MetricValue
ROE4.89%
ROA2.16%
ROCE9.48%
Gross Margin24.67%
Operating Margin24.67%
Net Margin6.81%
Debt/Equity0.74
Current Ratio1.16

Annual Financials (USD)

Metric20212022202320242025
Revenue$81.3B$100.3B$59.6B$63.6B$62.6B
Operating Profit$20.8B$37.5B$5.3B$16.5B$15.4B
Net Profit$22.1B$31.4B$2.1B$8.0B$7.8B
EPS$3.88$5.47$0.37$1.41$1.36
Op Margin25.6%37.4%8.9%25.9%24.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$181.5B$197.2B$226.5B$213.4B$208.2B
Total Liabilities$104.0B$101.3B$137.2B$124.9B$121.4B
Cash$1.9B$416.0M$2.9B$1.0B$1.1B
Borrowings$37.0B$34.9B$70.8B$67.0B$67.4B

Latest News

MetroLoft Leads $104M Office-to-Residential Bet in FiDi CRE Daily · Jul 16, 2026 Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price 24/7 Wall St. · Jul 15, 2026 Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King 24/7 Wall St. · Jul 15, 2026 Pfizer (PFE) Announces FDA Approval of PADCEV plus Keytruda in MIBC Insider Monkey · Jul 15, 2026 AM Best Affirms Credit Ratings of Blue Whale Re Ltd. Business Wire · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$32.6B$29.3B$8.7B$12.7B$11.7B
Investing Cash Flow$-25.3B$-19.0B$-36.2B$-257.0M$-4.0B
Financing Cash Flow$16.0M$-2.3B$-632.0M$-469.0M$-459.0M
Net Cash Flow$158.0M$-1.5B$2.4B$-1.8B$99.0M
Free Cash Flow$29.9B$26.0B$4.8B$9.8B$9.1B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.63
EV / EBITDA17.71
FCF Yield6.81%
Quick Ratio0.96
Interest Coverage5.92
Return 1Y21.63%
Return 3Y-6.20%
Return 5Y-24.98%

Ownership

Insiders Held0.10%
Institutions Held69.52%
Institutions Float Held69.59%
Institutional HolderSharesReport Date
Blackrock Inc.498,257,5502026-03-31
Vanguard Capital Management LLC369,430,0122026-03-31
State Street Corporation301,589,8652026-03-31
Geode Capital Management, LLC133,561,7422026-03-31
Vanguard Portfolio Management LLC116,734,6952026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMGN $438.12 +1.92% 27.15 $236.46B 2.29%
BMY $66.92 +0.16% 14.88 $136.70B 3.73%
BSX $48.08 -0.46% 19.42 $71.46B 0.00%
DHR $206.93 -3.10% 38.12 $145.47B 0.74%
GILD $149.92 +2.45% -56.96 $186.14B 2.21%

About PFE

PFE is led by CEO Albert Bourla, employs 81,000 people, headquartered in New York City, US, publicly traded since 1972.

PFE stock trades at $28.55 with a market capitalization of $162.72B. The stock is valued at a price-to-earnings (P/E) ratio of 37.39, price-to-book of 1.89, price-to-sales of 2.53. Over the past 52 weeks the stock has ranged between $23.58 and $29.03, and currently trades 1.7% below its 52-week high. It pays a dividend yielding 6.08%.

On profitability, PFE generates a return on equity (ROE) of 4.89%, return on capital employed of 9.48%, an operating margin of 24.67%, a net profit margin of 6.81%.

In its most recent fiscal year, PFE reported annual revenue of $62.6B, net profit of $7.8B, revenue has compounded at 8.5% a year over the last five years, profit at -3.2% a year.

The balance sheet shows a debt-to-equity ratio of 0.74, a current ratio of 1.16, total assets of $208.2B, $1.1B in cash and equivalents.

PFE has a beta of 0.28 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides